EFX

EFX

Equifax provides consumer credit reporting and data analytics services within the financial information industry.
It operates as one of the three major credit bureaus, with its core strength stemming from its extensive database of consumer credit data.

$219.77 +2.21 (+1.02%)

Updated: January 14, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy EFX Today?

Comprehensive Analysis of Equifax (EFX)

Technical Analysis EFX is entrenched in a pronounced downtrend, significantly underperforming the broader market over recent months. Trading near its 52-week low with heightened downside volatility suggests persistent selling pressure and an oversold condition. While this might tempt contrarian investors, the technical setup indicates continued weakness rather than a clear reversal signal.

Fundamentals The company shows stable revenue but faces profitability pressure from rising expenses, leading to declining net income. Financial health is adequate with reasonable debt levels and solid cash flow, though liquidity is somewhat tight. Operational efficiency appears mixed, with modest returns and potential underutilization of long-term assets.

Valuation & Risk Current valuation multiples appear stretched, signaling overvaluation unless future growth accelerates meaningfully. The stock carries high volatility risk, evidenced by its substantial drawdowns and sensitivity to market swings. Industry-specific risks, such as regulatory changes in data handling, remain pertinent considerations.

Investment Recommendation Based on the current analysis, EFX does not present a compelling buy opportunity at this time. The combination of technical weakness, profitability pressure, and premium valuation outweighs the modest fundamental strengths. Investors may consider waiting for improved earnings momentum, a more attractive valuation, or a clear technical reversal before establishing positions. This stock warrants monitoring but lacks the catalysts for immediate outperformance.

*Note: This is not investment advice, for reference only.*

CTA Banner

EFX 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, the 12-month outlook for Equifax (EFX) is cautious with a bias towards underperformance. Key negative catalysts include persistent selling pressure from the technical downtrend and continued pressure on profitability from rising operational expenses. The primary risk is the stock's premium valuation, which appears unsustainable without a significant acceleration in earnings growth that is not currently foreseen. While a bounce from oversold conditions is possible, the lack of positive momentum suggests a target range skewed to the downside of the current $217.56 price, with a retest of recent lows likely unless fundamental conditions improve.

Wall Street Consensus

Most Wall Street analysts are optimistic about EFX's 12-month outlook, with consensus target around $219.77, indicating expected upside potential.

Average Target
$219.77
23 analysts
Implied Upside
+0%
vs. current price
Analyst Count
23
covering this stock
Price Range
$176 - $286
Analyst target range
Buy Buy
15 (65%)
Hold Hold
8 (35%)
Sell Sell
0 (0%)

Bulls vs Bears: EFX Investment Factors

Overall, EFX has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Maintained Outperform Rating: Oppenheimer keeps bullish rating despite slight price target cut.
  • Recent Share Price Decline: Potential undervaluation after a near 10% price drop.
  • Strong Innovation Pipeline: Secured 27 new patents in H2 2025, totaling 62 for the year.
Bearish Bearish
  • Lowered Price Target: Oppenheimer reduced target price from $271 to $266.
  • Institutional Selling: Parnassus Investments cut its position in Equifax by 1.5%.
  • Regulatory Scrutiny: Stock declined after negative comments from FHFA Director on credit bureaus.
  • Underperformance vs. Market: Shares down 12.9% over six months, lagging S&P 500's gain.
Reward Banner

EFX Technical Analysis

EFX has demonstrated weak performance with a noticeable downtrend over recent months, underperforming the broader market significantly. The stock's negative returns across both short-term periods highlight persistent selling pressure and investor caution toward the company.

The stock has declined 1.38% over one month and 6.73% over three months, substantially underperforming the market by 10.1 percentage points during the latter period, indicating consistent relative weakness. Elevated beta of 1.558 confirms the stock's higher volatility is currently working to the downside, magnifying losses compared to the overall market.

Currently trading at $217.56, EFX sits just 8.8% above its 52-week low of $199.98, having recovered only modestly from its maximum drawdown of -27.22%. This proximity to recent lows, combined with prolonged underperformance, suggests the stock remains in oversold territory rather than presenting overbought conditions.

šŸ“Š Beta
1.56
1.56x market volatility
šŸ“‰ Max Drawdown
-27.2%
Largest decline past year
šŸ“ˆ 52-Week Range
$200-$281
Price range past year
šŸ’¹ Annual Return
-16.6%
Cumulative gain past year
Period EFX Return S&P 500
1m -0.5% +1.3%
3m -4.6% +5.7%
6m -17.3% +10.6%
1y -16.6% +16.5%
ytd +2.7% +1.1%

EFX Fundamental Analysis

Revenue & Profitability EFX demonstrates modest revenue growth with quarterly revenue increasing from $1.537B to $1.545B while maintaining stable gross margins around 57%. However, profitability metrics show pressure as net income declined from $191M to $160M quarter-over-quarter, with net margin contracting from 12.4% to 10.4% primarily due to higher operating expenses.

Financial Health The company maintains moderate leverage with a debt-to-equity ratio of 0.97 and total debt to capitalization of 49%. While the current ratio of 0.74 indicates potential liquidity constraints, strong cash flow generation is evidenced by operating cash flow per share of $4.55 and interest coverage of 5.1 times, providing adequate debt service capacity.

Operational Efficiency EFX shows moderate operational efficiency with return on equity of 3.2% and asset turnover of 0.13. The 59-day receivables collection period suggests reasonable working capital management, though the low fixed asset turnover of 0.44 indicates potential underutilization of long-term assets relative to revenue generation capacity.

Quarterly Revenue
$1.5B
2025-09
Revenue YoY Growth
+8.0%
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
$0.8B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is EFX Overvalued?

Valuation Level: EFX appears significantly overvalued based on its current ratios. Its high TTM and forward PE ratios, elevated PB and PS multiples, and an exceptionally high EV/EBITDA all point to a premium valuation. The negative PEG ratio is particularly concerning as it suggests either negative earnings growth or a calculation anomaly, making the standard PE ratio a more relevant but still unfavorable indicator.

Peer Comparison: A precise valuation assessment is limited as specific industry average data was not provided. For a conclusive peer comparison, it would be necessary to benchmark these multiples against the averages for the professional services or data analytics industry to determine if EFX's premium is justified relative to its competitors.

Current PE
54.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 27Ɨ-73Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
80.3x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: EFX exhibits significant volatility risk with a beta of 1.558, indicating it is approximately 56% more volatile than the broader market. This elevated sensitivity is further evidenced by a substantial one-year maximum drawdown of -27.22%, reflecting a considerable potential for sharp price declines during market turbulence. Investors should be prepared for above-average price swings.

Other Risks: The absence of reported short interest suggests no significant speculative bets against EFX, which can be a positive signal regarding market sentiment. However, this singular metric does not eliminate other potential risks, such as regulatory pressures specific to the credit reporting industry or shifts in consumer data privacy trends.

FAQs

Is EFX a good stock to buy?

Bearish. EFX faces pressure from declining profitability, an overvalued profile despite recent price drops, and regulatory headwinds. The stock's high volatility and underperformance relative to the market add to the near-term risk. This may only suit highly risk-tolerant, contrarian investors looking for a potential turnaround, as the current setup lacks clear catalysts.

Is EFX stock overvalued or undervalued?

EFX stock appears overvalued based on its current valuation multiples relative to reasonable expectations. The stock trades at elevated PE (55.6), forward PE (49.3), and PS (6.0) ratios, which are significantly higher than typical market averages. This premium valuation is difficult to justify given the company's declining profitability (net income fell from $191M to $160M last quarter) and modest revenue growth, particularly when coupled with operational efficiency metrics like a low 3.2% ROE. The negative PEG ratio further indicates that earnings growth isn't supporting the high multiples.

What are the main risks of holding EFX?

Of course. Based on the provided information, here are the key risks of holding Equifax (EFX) stock, ordered by importance.

1. Market Volatility and Technical Weakness: The stock's high beta (1.558) indicates it is prone to significantly sharper price declines than the broader market during downturns, a risk confirmed by its substantial -27.22% maximum drawdown and consistent underperformance. 2. Profitability and Margin Pressure: Despite modest revenue growth, the company faces a clear risk of declining profitability, as evidenced by a recent quarter-over-quarter drop in net income from $191M to $160M and a contracting net margin due to rising operating expenses. 3. Liquidity and Operational Constraints: The company exhibits a risk of short-term financial strain, signaled by a current ratio of 0.74 (below 1.0), which may limit flexibility, compounded by indications of underutilized assets (low fixed asset turnover of 0.44). 4. Industry-Specific and Regulatory Headwinds: As a credit reporting agency, EFX faces inherent risks from potential shifts in consumer data privacy regulations and lending trends, which could directly impact its core business model, even in the absence of immediate negative signals like high short interest.

What is the price forecast for EFX in 2026?

Based on the provided analysis projecting current trends forward, the EFX stock forecast through 2026 is for moderate growth with significant execution risk.

1. 2026 Target Price Range: * Base Case: $230 - $260 * Bull Case: $280 - $310

2. Key Growth Drivers: The primary catalysts would be a successful reversal of the profitability pressures through cost management and a re-acceleration of earnings growth that justifies its valuation premium.

3. Main Assumptions: This forecast assumes Equifax can stabilize its net margins, manage its operational expenses effectively, and that its moderate leverage does not become a constraint on growth.

4. Uncertainty: The forecast carries high uncertainty, heavily dependent on improved operational execution; failure to address profitability concerns could result in minimal price appreciation or further downside from current levels.